MSLN and pancreatic neoplasm: Taken together, these findings suggest that HSV-MSLN effectively delivers MSLN to infected cells, induces the lysis of pancreatic cancer cells, releasing mediators that promote DCs maturation and potentially shift the TME to a more immunogenically active status.